Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement

Exercise Clinical Trial

Official title:

Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01184040
• Other study ID #: 10-249-1
• Secondary ID: 1P30DA023918-01A
• Status: Completed
• Phase: N/A
• Start date: May 2010
• Est. completion date: March 2012

Study information

• Verified date: April 2019
• Source: UConn Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Contingency Management (CM) is highly effective in promoting recovery from substance use disorders, but benefits tend to attenuate over time when CM is discontinued. Identifying modifications of CM delivery that can extend its benefits is an important goal. The goal of this study is to evaluate the use of reinforcements to increase physical activity, specifically walking. The study provides a standard CM intervention to promote walking for three weeks. After three weeks, a progressively increasing variable interval schedule of reinforcement will be evaluated for increasing the durability of effects of the initial CM intervention. We hypothesize that Variable Interval Prize Contingency Management will result in greater adherence to a walking goal of 10,000 steps per day at Week 15 and Week 24 compared to the Control Condition.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: March 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age > 18 years

• currently not physically active

• Physically able and willing to walk 10,000 steps per day

Exclusion Criteria:

• psychiatric or physical illness that could interfere with participation

Related Conditions & MeSH terms

• Addictive Behaviors
• Behavior, Addictive
• Exercise

Intervention

Behavioral:
• VIP CM
Participants will receive progressively increasing CM for walking 10,000 steps per day over 4 days prior to visit as verified by the pedometer.

Locations

Country	Name	City	State
United States	UConn Heatlh Center	Farmington	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
UConn Health	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of steps walked in seven days prior to follow up assessment, as verified by the pedometer		week 15
Primary	number of steps walked in seven days prior to follow up assessment, as verified by the pedometer		week 24